Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Bird flu cases are still rising in the U.S. as the virus continues to devastate poultry farms. More than 145 million chickens ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

“In Asia, people buy live birds at markets where they are plucked. The plucking has been shown to aerosolize virus from the ...